Dm. Goodhart et Tj. Anderson, ROLE OF NITRIC-OXIDE IN CORONARY ARTERIAL VASOMOTION AND THE INFLUENCE OF CORONARY ATHEROSCLEROSIS AND ITS RISKS, The American journal of cardiology, 82(9), 1998, pp. 1034-1039
Healthy coronary vascular endothelium releases nitric oxide to modulat
e resting and dynamic coronary arterial cone. We studied the impact of
atherosclerosis and/or ifs risks on endothelial nitric oxide release
in response to metabolic stimuli by evaluating coronary vasomotor resp
onses to atrial pacing before and after the inhibition of nitric oxide
production by intracoronary NG-monomethyl-L-arginine (L-NMMA) (20 mu
mol/min) infusion. The study includes 34 patients (15 with coronary di
sease, 11 with normal coronary arteries and greater than or equal to 1
risk factor, and 8 with normal coronary arteries and no risks). Coron
ary blood flow was derived from Doppler flow velocity (0.018-inch Dopp
ler wire) and coronary diameter. L-NMMA infusion reduced coronary bloo
d flow by 18 +/- 16% and coronary diameter by 10 +/- 9%. Responses wer
e identical in all subgroups. Coronary blood flow responses to pacing
were similar in all subgroups and were unaffected by L-NMMA (11 +/- 11
vs 13 +/- 9 ml/min; p = 0.26). Epicardial coronary vasodilation to co
ntrol pacing occurred in patients with normal coronary arteries with (
4.0 9 +/- 5.2%, p = 0.01) or without (8.0 +/- 5.2%, p = 0.03) risks, b
ut not in patients with coronary disease (2.8 +/- 5.9%). L-NMMA abolis
hed pacing-induced epicardial vasodilation in patients without coronar
y artery disease, producing a 1.8 +/- 5.1% response, which was similar
in all subgroups, We conclude that microvascular responses to rapid a
trial pacing are not mediated by nitric oxide. Flow-mediated epicardia
l coronary arterial responses may be nitric oxide dependent. (C)1998 b
y Excerpta Medico, Inc.